Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin for Kaposiform Hemangioendothelioma in Infants
ChiCTR-OIC-16008525Phase 2Recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sirolimus in kaposiform hemangioendothelioma (KHE), sponsored by Guangzhou Women and Children's Medical Center. Started Jun 2016; status: recruiting.
02
Drugs
sirolimus
03
Conditions
kaposiform hemangioendothelioma (KHE)
Beyond the preview
Go deeper on ChiCTR-OIC-16008525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIC-16008525.